Study to Assess Adverse Events (AEs) When Oral Atogepant Tablet is Given to Adult Chinese Participants Who Completed Study 3101-303-002 to Prevent Chronic Migraine

NCT04829747 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
3
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Allergan